JP MORGAN/PUT/METLIFE/64/0.1/17.01.25 Stock

JP MORGAN/PUT/METLIFE/64/0.1/17.01.25 Share Price

DE000JL7KC75

Market Closed - Börse Stuttgart 15:18:50 04/07/2024 BST
0.2 ^EUR	0.00%

Current month	+5.26%
3 months	-16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart METLIFE, INC.

Chart JP MORGAN/PUT/METLIFE/64/0.1/17.01.25

Latest news about METLIFE, INC.

JPMorgan Adjusts Price Target on MetLife to $86 From $81, Maintains Overweight Rating	07-02	MT
Jefferies Adjusts Price Target on MetLife to $83 From $88, Maintains Buy Rating	06-28	MT
Salesforce challenger Creatio achieves $1.2 bln 'unicorn' status with fundraising	06-26	RE
MetLife's Latest Sustainability Report Demonstrates How It Lives Its Purpose	06-26	AQ

More news

Quotes 5-day view

Date	Price	Change
04/07/24	0.2	0.00%
03/07/24	0.2	-4.76%
02/07/24	0.21	+5.00%
01/07/24	0.2	+5.26%
28/06/24	0.19	0.00%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 03:18 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	PUT
Underlying	METLIFE, INC.
Issuer	J.P. Morgan
WKN	JL7KC7
ISIN	DE000JL7KC75
Date issued	28/07/2023
Strike	64 $
Maturity	17/01/2025 (197 Days)
Parity	10 : 1
Emission price	0.72 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.03 €
Lowest since issue	0.17 €
Delta	-0.26x
Omega	7.459
Premium	12.32x
Gearing	28.21x
Moneyness	0.9122
Difference Strike	-6.16 $
Difference Strike %	-9.63%
Spread	0.06 €
Spread %	23.08%
Theoretical value	0.2300
Implied Volatility	27.06 %
Total Loss Probability	66.80 %
Intrinsic value	0.000000
Present value	0.2300
Break even	61.51 €
Theta	-0.01x
Vega	0.02x
Rho	-0.01x

Company Profile

MetLife, Inc. is one of the leading American insurance groups. Premiums issued break down by activity as follows: - life insurance (58.2%): sales of savings, pre-planning, and annuities insurance policies; - accident and health insurance (39.7%); - property and casualty insurance (2.1%). Premiums are distributed geographically as follows: the United States (64.2%), Asia (15.7%), Latin America (6.4%), Europe/Middle East/Africa (5.5%) and other (8.2%).

Sector

More about the company

Ratings for MetLife, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Consensus: MetLife, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

70.16 USD

Average target price

82.41 USD

Spread / Average Target

+17.46%

Consensus